Document is current
Any future updates will be listed below
-
Authors
Koizumi, Miyuki
Nakajima, Hiroki
Nishioka, Yuichi
Morita, Emiri
Myojin, Tomoya
Noda, Tatsuya
Imamura, Tomoaki
Takahashi, Yutaka
-
Funding
Funding for this research was provided by:
Japan Ministry of Education, Culture, Sports, Science and Technology (23K16362)
Japan Ministry of Education, Culture, Sports, Science and Technology (22H03355, 23K24613, 24K22341)
- License Information
-
More Information
Article History
Received: 9 May 2025
Accepted: 6 February 2026
First Online: 11 February 2026
Declarations
:
: This study was approved by the Ethics Committee of Nara Medical University (approval no. 1123) and conducted in accordance with the principles outlined in the Declaration of Helsinki. Only anonymized secondary administrative claims data provided for research purposes were used; therefore, the requirement for informed consent to participate was waived by the Ethics Committee of Nara Medical University.
: Not applicable.
: YN received speaker fees from Novo Nordisk, Sanofi, Daiichi Sankyo, and DeSC Healthcare. YT received consultant fees from Novo Nordisk, Otsuka, and Recordati, and speaker fees from Novo Nordisk, Sumitomo Dainippon, Eli Lilly, Ono, Novartis, Nippon Boehringer Ingelheim, AstraZeneca, and Kyowa Kirin. The other authors declare no competing interests.
